Vildagliptin 50 mg + Metformin Hydrochloride 1000 mg

Vildabate M 1000

Metformin (1000mg)SR, Vildagliptin (50mg)

Diabetes, especially type 2, has become a major health concern worldwide, affecting millions of people. The need for effective medication to manage blood glucose levels is crucial. Vildiabate M 1000 is a combination drug designed to help people with type 2 diabetes control their blood sugar levels. The formulation combines two active ingredients: Metformin (1000mg) and Vildagliptin (50mg), both of which work synergistically to offer comprehensive glycemic control. In this article, we will explore the composition, key benefits, and usage of Vildiabate M 1000, providing a clear understanding of its therapeutic potential.

Composition:

Vildiabate M 1000 contains two key active ingredients:

1. Metformin (1000mg) SR (Sustained Release): Metformin is an oral medication widely used to treat type 2 diabetes. It works primarily by improving the body’s sensitivity to insulin, reducing glucose production in the liver, and enhancing glucose uptake by muscle cells. The sustained-release formulation ensures that the drug is released slowly over time, helping maintain stable blood sugar levels throughout the day.

2. Vildagliptin (50mg): Vildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps control blood sugar levels by increasing insulin secretion and decreasing glucagon levels, especially after meals. It works by enhancing the effect of incretin hormones, which regulate insulin and glucagon release, thus improving postprandial (after meal) blood sugar control.

Together, these two ingredients make Vildiabate M 1000 an effective solution for managing blood glucose levels in patients with type 2 diabetes.

Key Features and Ingredients:

• Metformin (1000mg) SR: The sustained-release formulation of Metformin helps avoid the peaks and troughs in drug concentration associated with immediate-release forms. This leads to improved adherence, better glycemic control, and fewer gastrointestinal side effects.

• Vildagliptin (50mg): Vildagliptin works by inhibiting the DPP-4 enzyme, which breaks down incretin hormones like GLP-1. By preventing this breakdown, Vildagliptin enhances insulin secretion in response to meals and lowers glucagon secretion, both of which help regulate blood glucose levels.

• Dual Action: The combination of Metformin and Vildagliptin provides a dual mechanism of action: Metformin primarily reduces insulin resistance and hepatic glucose production, while Vildagliptin increases insulin secretion and reduces glucagon levels, particularly after meals.

Usage:

Vildiabate M 1000 is typically prescribed for patients with type 2 diabetes who require additional blood glucose control after diet and exercise alone have proven insufficient. The dosage depends on the individual patient’s blood sugar levels, kidney function, and tolerance to the drug. It is often used in combination with other antidiabetic agents when monotherapy does not provide adequate glycemic control.

• How to take Vildiabate M 1000: This medication is usually taken once daily with food to minimize gastrointestinal discomfort. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Dosage adjustments may be required depending on the patient’s blood sugar levels and overall health condition.

• Monitoring: Regular monitoring of blood sugar levels and kidney function is essential during treatment with Vildiabate M 1000. It is also important to monitor for any side effects or drug interactions with other medications the patient may be taking.

Benefits:

1. Effective Blood Sugar Control: The combination of Metformin and Vildagliptin ensures comprehensive blood sugar management by addressing multiple pathways involved in glucose metabolism, helping to keep blood sugar levels stable throughout the day.

2. Dual Mechanism of Action: By combining the actions of Metformin and Vildagliptin, Vildiabate M 1000 provides a more effective treatment for type 2 diabetes compared to single-agent therapies. Metformin reduces insulin resistance and liver glucose production, while Vildagliptin increases insulin secretion and reduces postprandial glucose spikes.

3. Minimal Risk of Hypoglycemia: Both Metformin and Vildagliptin have a low risk of causing hypoglycemia (low blood sugar), particularly when used alone or with other non-insulin antidiabetic drugs. This makes Vildiabate M 1000 a safer option for long-term use in type 2 diabetes management.

4. Convenient Dosing: The sustained-release formulation of Metformin allows for once-daily dosing, improving patient compliance and convenience while maintaining effective blood glucose control over the 24-hour period.

5. Improved Insulin Sensitivity: Metformin improves insulin sensitivity, allowing the body to use insulin more effectively. This can be especially beneficial for overweight patients with insulin resistance.

6. Postprandial Blood Sugar Control: Vildagliptin’s action on incretin hormones ensures better control of blood sugar levels after meals, which is critical for managing overall glycemic control in type 2 diabetes.

7. Weight Neutral: Unlike some other diabetes medications, Vildiabate M 1000 does not typically cause weight gain, which is an important consideration for people with type 2 diabetes who are also struggling with obesity.

Conclusion:

Vildiabate M 1000 is a highly effective treatment for type 2 diabetes, offering dual-action control over blood glucose levels through the combination of Metformin and Vildagliptin. By addressing both insulin resistance and insulin secretion, this medication helps patients achieve better glycemic control while minimizing the risk of hypoglycemia and weight gain. The sustained-release formulation enhances patient compliance, and its once-daily dosing regimen makes it a convenient option for long-term diabetes management. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, Sterisonline,  Sterisindia and Sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

BUY NOW